- Home
- LIEN vs ANGO Comparison
LIEN vs ANGO Comparison
Compare LIEN & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIEN
- ANGO
- Stock Information
- Founded
- LIEN 2021
- ANGO 1988
- Country
- LIEN United States
- ANGO United States
- Employees
- LIEN N/A
- ANGO N/A
- Industry
- LIEN
- ANGO Medical/Dental Instruments
- Sector
- LIEN
- ANGO Health Care
- Exchange
- LIEN NYSE
- ANGO Nasdaq
- Market Cap
- LIEN 234.6M
- ANGO 400.8M
- IPO Year
- LIEN 2022
- ANGO 2004
- Fundamental
- Price
- LIEN $10.75
- ANGO $9.33
- Analyst Decision
- LIEN Buy
- ANGO Strong Buy
- Analyst Count
- LIEN 2
- ANGO 2
- Target Price
- LIEN N/A
- ANGO $15.50
- AVG Volume (30 Days)
- LIEN 61.1K
- ANGO 570.7K
- Earning Date
- LIEN 08-07-2025
- ANGO 07-15-2025
- Dividend Yield
- LIEN 12.66%
- ANGO N/A
- EPS Growth
- LIEN 30.25
- ANGO N/A
- EPS
- LIEN 1.15
- ANGO N/A
- Revenue
- LIEN $30,828,508.00
- ANGO $283,320,000.00
- Revenue This Year
- LIEN $154.46
- ANGO N/A
- Revenue Next Year
- LIEN $10.64
- ANGO $6.35
- P/E Ratio
- LIEN $9.31
- ANGO N/A
- Revenue Growth
- LIEN 151.96
- ANGO N/A
- 52 Week Low
- LIEN $9.70
- ANGO $5.67
- 52 Week High
- LIEN $13.38
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- LIEN N/A
- ANGO 43.45
- Support Level
- LIEN N/A
- ANGO $9.12
- Resistance Level
- LIEN N/A
- ANGO $9.78
- Average True Range (ATR)
- LIEN 0.00
- ANGO 0.40
- MACD
- LIEN 0.00
- ANGO -0.09
- Stochastic Oscillator
- LIEN 0.00
- ANGO 26.24
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company is an externally managed, closed-end, non-diversified management investment company with an investment objective to maximize risk-adjusted returns on equity for its stockholders by investing in direct loans to privately held middle-market companies, with a focus on cannabis companies.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.